Lyrica (pre-gabalin) Suffers Setback
home > feedster
Pfizer Drug Lyrica Suffers a Setback By SCOTT HENSLEY Staff Reporter of THE WALL STREET JOURNAL January 3, 2005; Page B2 Pfizer Inc. was dealt an unexpected blow as federal regulators indicated they would classify Lyrica, a drug to treat persistent nerve pain, as a controlled substance, even as the Food and Drug Administration finally approved it for sale. The mixed decision is a
- link to Lyrica (pre-gabalin) Suffers Setback -
Last update: 06/01/2005